Omicron variant: Group of local researchers discusses vaccine effectiveness against the new SARS-CoV-2 variant
Omicron variant: Group of local researchers discusses vaccine effectiveness against the new SARS-CoV-2 variant
Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID (click here).
Professor Daniel Janies (Charlotte’s Department of Bioinformatics and Genomics) and other local researchers discuss vaccine effectiveness against the new SARS-CoV-2 variant, called omicron (B.1.1.529). Click here to read the original article by Elsa Gillis (wsoctv.com).
Dr. Janies said researchers “made a computational prediction that there will be somewhat less efficiency of the vaccines” but that “should be confirmed with lab testing which should take a couple of weeks.” As we wait to learn more, people are wondering if vaccines will protect them. According to Dr. Janies, people should “seek a vaccine, they are still tremendously effective.”
The B.1.1.529 variant was first reported to WHO from South Africa on 24 November 2021. On November 26, WHO classified omicron as a “Variant of Concern” (click here).
Source
“Group of local researchers discuss vaccine effectiveness against omicron COVID-19 variant,” by Elsa Gillis (wsoctv.com). Click here to read the full article.